Income Statement

NEUPHORIA THERAPEUTICS INC.

NEUP

Performance Overview Click any row in the table to add it to this chart

in millions USD

Metric	Jun 30, 2025 2025 FY	Jun 30, 2024 2024 FY
Revenue	15.65	-
Cost of Revenue	-	-
Gross Profit	15.65	-
Operating Expenses	16.78	17.89
Research & Development	9.01	9.42
Selling, General & Administrative	7.77	8.47
Other Operating Expenses	-	-
Operating Income	-1.13	-17.89
Non-Operating Income	0.29	2.31
Interest Income	0.17	0.22
Interest Expense	-	-
Other Non-Op Income / Expense	-	-
Income Before Tax	-0.84	-15.58
Income Tax Expense	-0.47	-0.09
Non-Controlling Interest	-	-
Net Income	-0.37	-15.49

Supplemental Per share data, derived & other items — not part of the income statement

in millions USD unless noted